No serious adverse effects have been observed with<unk>  in early clinical trials but there is limited evidence Slightly higher frequency of complaints such as pharyngitis, headaches and allergic dermatitis are reported by individuals taking<unk> . Headache frequency was higher in patients receiving<unk>  over placebo in both phase 1 and phase 2 clinical trials for<unk> .
EMA401
MRK-016
AEMT-CC
OSU-6162
ICE 
HAMLET 
ZF2001
DEBRA